Each day matters

Individual results may vary.

Each.

More mothers may be living with PPD than you think.2

About 1 in 9 moms suffers from PPD.2

Day.

ZULRESSO is thought to work differently.1

A positive allosteric modulator of GABA receptors.1

Matters.

Safety information across 3 studies.1,3

Patients are at risk for excessive sedation or sudden loss of consciousness during administration of ZULRESSO. If excessive sedation occurs at any time during the infusion, stop the infusion until the symptoms resolve.1

ZULRESSO is the first and only FDA-approved treatment indicated for postpartum depression.1

Individual results may vary.
Not actual patients.

Your next patient 
could see a reduction 
in PPD symptoms.1

Clinical trials showed that ZULRESSO can help women experience a reduction in depressive symptoms as measured by change in HAM-D total score at Hour 60.1

Individual results may vary.

Each.
Day.
Matters.

ZULRESSO is the first and only FDA-approved treatment indicated for postpartum depression.1

Individual results may vary.

Not actual patients.

More mothers may be living with PPD than you think.2

About PPD

ZULRESSO is thought to work differently.1

Mechanism of action

Safety information across 3 studies.1,3

Safety profile

ZULRESSO
efficacy.

Clinical trial data